Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy.
Aged
Betacoronavirus
COVID-19
Coronavirus Infections
/ epidemiology
Female
Head and Neck Neoplasms
/ radiotherapy
Humans
Infection Control
/ organization & administration
Infectious Disease Transmission, Patient-to-Professional
Italy
/ epidemiology
Male
Middle Aged
Occupational Health
Pandemics
/ prevention & control
Patient Safety
Personal Protective Equipment
Pneumonia, Viral
/ epidemiology
Practice Patterns, Physicians'
/ organization & administration
Radiotherapy, Image-Guided
Radiotherapy, Intensity-Modulated
SARS-CoV-2
Workflow
COVID-19
departmental procedures
head and neck cancer
health care protections
radiation oncology
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
16
05
2020
accepted:
20
05
2020
pubmed:
20
6
2020
medline:
21
7
2020
entrez:
20
6
2020
Statut:
ppublish
Résumé
Management of head and neck cancers (HNC) in radiation oncology in the coronavirus disease 2019 (COVID-19) era is challenging. Aim of our work is to report organization strategies at a radiation therapy (RT) department in the first European area experiencing the COVID-19 pandemic. We focused on (a) dedicated procedures for HNC, (b) RT scheduling, and (c) health care professionals' protection applied during the COVID-19 breakdown (from March 1, 2020 to April 30, 2020). Applied procedures are reported and discussed. Forty-three patients were treated. Image-guided, intensity modulated RT was performed in all cases. Median overall treatment time was 50 (interquartile range: 47-54.25) days. RT was interrupted/delayed in seven patients (16%) for suspected COVID-19 infection. Two health professionals managing HNC patients were proven as COVID-19 positive. Adequate and well-timed organization allowed for the optimization of HNC patients balancing at the best of our possibilities patients' care and personnel's safety.
Sections du résumé
BACKGROUND
BACKGROUND
Management of head and neck cancers (HNC) in radiation oncology in the coronavirus disease 2019 (COVID-19) era is challenging. Aim of our work is to report organization strategies at a radiation therapy (RT) department in the first European area experiencing the COVID-19 pandemic.
METHODS
METHODS
We focused on (a) dedicated procedures for HNC, (b) RT scheduling, and (c) health care professionals' protection applied during the COVID-19 breakdown (from March 1, 2020 to April 30, 2020).
RESULTS
RESULTS
Applied procedures are reported and discussed. Forty-three patients were treated. Image-guided, intensity modulated RT was performed in all cases. Median overall treatment time was 50 (interquartile range: 47-54.25) days. RT was interrupted/delayed in seven patients (16%) for suspected COVID-19 infection. Two health professionals managing HNC patients were proven as COVID-19 positive.
CONCLUSION
CONCLUSIONS
Adequate and well-timed organization allowed for the optimization of HNC patients balancing at the best of our possibilities patients' care and personnel's safety.
Identifiants
pubmed: 32557972
doi: 10.1002/hed.26319
pmc: PMC7323327
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1482-1490Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Head Neck. 2020 Jun;42(6):1173-1178
pubmed: 32329953
Radiother Oncol. 2012 Sep;104(3):343-8
pubmed: 22853852
Clin Oncol (R Coll Radiol). 2020 Jul;32(7):e160-e161
pubmed: 32354669
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Head Neck. 2020 Jun;42(6):1214-1217
pubmed: 32329948
JAMA Otolaryngol Head Neck Surg. 2020 May 1;146(5):455-464
pubmed: 32239201
Strahlenther Onkol. 2016 Jun;192(6):377-85
pubmed: 26972085
J Otolaryngol Head Neck Surg. 2015 May 13;44:17
pubmed: 25964113
Radiother Oncol. 2020 Oct;151:314-321
pubmed: 32730830
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
Graefes Arch Clin Exp Ophthalmol. 2020 May;258(5):1049-1055
pubmed: 32124000
Head Neck. 2020 Jul;42(7):1367-1373
pubmed: 32358855
Lancet. 2020 Mar 7;395(10226):760-762
pubmed: 32151334
Phys Med. 2015 Dec;31(8):1015-1021
pubmed: 26459318
Otolaryngol Head Neck Surg. 2020 Jun;162(6):804-808
pubmed: 32286909
Clin Infect Dis. 2020 Nov 19;71(16):2218-2221
pubmed: 32179890
Front Oncol. 2020 Mar 24;10:398
pubmed: 32266158
Head Neck. 2020 Jun;42(6):1259-1267
pubmed: 32270581
Oral Oncol. 2020 Mar;102:104561
pubmed: 31918175
JAMA Otolaryngol Head Neck Surg. 2019 Feb 1;145(2):166-177
pubmed: 30383146
Head Neck. 2020 Jun;42(6):1147-1149
pubmed: 32343444
Head Neck. 2020 Jun;42(6):1150-1152
pubmed: 32338797
Acta Oncol. 2013 Feb;52(2):270-6
pubmed: 23173758
Curr Treat Options Oncol. 2017 Jul;18(7):40
pubmed: 28555375
Eur Ann Otorhinolaryngol Head Neck Dis. 2020 May;137(3):159-160
pubmed: 32303485
Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):600-601
pubmed: 32199942
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Head Neck. 2020 Jul;42(7):1482-1490
pubmed: 32557972
J Otolaryngol Head Neck Surg. 2017 Apr 4;46(1):29
pubmed: 28376866